Effect of 593C>T GPx1 SNP alone and in synergy with 47C>T SOD2 SNP on the outcome of critically ill patients

Cytokine

Volumn 71, Issue 2, 2015, Pages 312-317

  Majolo, Fernanda ^a,b   Oliveira Paludo, Francis Jackson de ^c   Ponzoni, Aline ^a   Graebin, Pietra ^a   Dias, Fernando Suparregui ^a   Alho, Clarice Sampaio ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b CENTRO UNIVERSITÁRIO UNIVATES   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Critical illness; GPx1; Sepsis; Septic shock; SOD2

Indexed keywords

GLUTATHIONE PEROXIDASE 1; MANGANESE SUPEROXIDE DISMUTASE; CATALASE; FREE RADICAL; GLUTATHIONE PEROXIDASE; OXYGEN; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENOTYPE; GPX1 GENE; HOMOZYGOSITY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PHENOTYPE; SEPSIS; SEPTIC SHOCK; SINGLE NUCLEOTIDE POLYMORPHISM; SOD2 GENE; ALLELE; CHEMISTRY; CRITICAL ILLNESS; GENETICS; GENOMICS; HOMOZYGOTE; INTENSIVE CARE; METABOLISM; TREATMENT OUTCOME;

ALLELES; CATALASE; CRITICAL ILLNESS; FREE RADICALS; GENOMICS; GENOTYPE; GLUTATHIONE PEROXIDASE; HOMOZYGOTE; HUMANS; INTENSIVE CARE; OXYGEN; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEPSIS; SHOCK, SEPTIC; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME;

EID: 84916899251     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.10.020     Document Type: Article

References (46)

1. Vincent J.L. The magnitude of the problem. The Sepsis Text 2002, Kluwer Academy Publisher.
2. Siqueira-Batista R., Gomes A.P., Pessoa-Júnior V.P. Sepse, em: Rocha MOC, Pedroso ERP. Fundamentos Em Infectologia 2009, 567-590. Rubio, Rio de Janeiro.
3. Manzanares W., Dhaliwal R., Jiang X., Murch L., Heyland D.K. Antioxidant micronutrients in the critically ill a systematic review and meta-analysis. Crit Care 2012, 16(2).
4. Goodyear-Bruch C., Pierce J.D. Oxidative stress in critically ill patients. Am J Crit Care 2002, 11:543-561.
5. Lovat R., Preiser J.C. Antioxidant therapy in intensive care. Crit Care 2003, 9:266-270.
6. Victor V.M., Rocha M., De la Fuente M. Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmacol 2004, 4:327-347.
7. Berger M.M. Can oxidative damage be treated nutritionally?. Clin Nutr 2005, 24:172-183.
8. Frost M.T., Wang Q., Moncada S., Singer M. Hypoxia accelerates nitric oxid dependent inhibition of mitochondrial complex I in activated macrophages. Am J Physiol Regul Integr Comp Physiol 2005, 288:R394-R400.
9. Alonso de Vega J.M., Díaz J., Serrano E., Carbonell L.F. Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 2002, 30:1782-1786.
10. Motoyama T., Okamoto K., Kukita I., Hamaguchi M., Kinoshita Y., Ogawa H. Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 2003, 31:1048-1052.
11. Berger M.M., Chiólero R. Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med 2007, 35:S584-S590.
12. Paludo F.J.O., Picanço J.B., Fallavena P.R.V., Fraga L.R., Graebin P., Nóbrega O.T., et al. Higher frequency of septic shock in septic patients with the 47C allele (rs4880) of the SOD2 gene. Gene 2013, 517(1):106-111.
13. Hiroi S., Harada H., Nishi H., Satoh M., Nagai R., Kimura A. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem Biophys Res Commun 1999, 261:332-339.
14. Williams M.D., Van Remmen H., Conrad C.C., Huang T.T., Epstein C.J., Richardson A. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J Biol Chem 1998, 273(43):28510-28515.
15. YU B.P. Cellular defenses against damage from reactive oxygen species. Physiol Ver 1994, 74:139-162.
16. Mills G.C. Hemoglobin catabolism. I: Glutathione peroxidase, an erythrocyte enzyme which protects hemoglobin from oxidative breakdown. J Biol Chem 1957, 229:189-197.
17. Lei X.G. Glutathione peroxidase-1 gene knockout on body antioxidant defense in mice. BioFactors 2001, 14:93-99.
18. Hu Y.J., Diamond A.M. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 2003, 63:3347-3351.
19. Fallavena P.R.V., Jesus B.T.de., Paskulin D.D., Thurow H.S., de Oliveira Paludo F.J., dos Santos Froes C., et al. The Synergy of -260TT CD14 and -308GG TNF-a Genotypes in Survival of Critically Ill Patients. Hum Immunol 2012, 77:62-68.
20. Fraga L.R., Paludo F.J.O., Bós A.J.G., Ferraro J.L.S., Dias F.S., Alho C.S. More severe clinical course of cardiovascular dysfunction in intensive care unit patients with the 894TT eNOS genotype. Genet Mol Res 2013, 12(1):562-568.
21. Parra F.C., Amado R.C., Lambertucci J.R., Rocha J., Antunes C.M., Pena S.D. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci 2003, 100:177-182.
22. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest 1992, 101:1644-1655.
23. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
24. Vincent J.L., de Mendonça A., Cantraine F., Moreno R., Takala J., Suter P.M., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med 1998, 26:1793-1800.
25. Lahiri D.K., Nurnberger J.J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991, 19:5444.
26. Hansen R.D. GPx1 Pro(198)Leu polymorphism, erythrocyte GPx activity, interaction with alcohol consumption and smoking, and risk of colorectal cancer. Mutat Res 2009, 664(1-2):13-19.
27. Gurbuzier l, Sogut E., Koc S., Eyibilen A., Yelken K., Senkal Ha, et al. Manganese-superoxide dismutase and glutathione peroxidase 1 polymorphisms in recurrent tonsillitis and tonsillar hypertrophy. Int J Pediatr Otorhinolaryngol 2012, 76(9):1270-1273.
28. Zhao P., Zhao L., Zou P., Lu A., Liu N., Yan W., et al. Genetic oxidative stress variants and glioma risk in a Chinese population: a hospital-based case-control study. BMC Cancer 2012, 12:617.
29. Ramprasath T., Murugan P.S., Kalaiarasan E., Gomathi P., Rathinavel A., Selvam G.S. Genetic association of Glutathione peroxidase 1 (GPx1) and NAD(P)H:Quinone Oxidoreductase 1(NQO1) variants and their association of CAD in patients with type-2 diabetes. Mol Cell Biochem 2012, 361(1-2):143-150.
30. Johnson Phillips J.A., Mauer C., Edwards M., Balldin V.H., Hall J.R., Barber R., et al. The impact of GPx1 on the association of groundwater selenium and depression: a project Frontier study. BMC Psychiatry 2013, 13:7.
31. Zheikova T.V., Golubenko M.V., Buikin S.V., Botkina O.Y., Makeeva O.A., Lezhnev A.A., et al. Glutathione peroxidase 1 (GPx1) single nucleotide polymorphism Pro198→Leu: Association with life span and coronary artery disease. Mol Biol 2012, 46:433-437.
32. Kucukgergin C., Gokpinar M., Sanli O., Tefik T., Oktar T., Seckin S. Association between genetic variants in glutathione peroxidase 1 (GPx1) gene, GPx activity and the risk of prostate cancer. J Nephrol Urol 2011, 63(3):183-190.
33. Kucukgergin C., Isman F.K., Cakmakoglu B., Sanli O., Seckin S. Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer. DNA Cell Biol 2012, 31(8):1418-1424.
34. Ratnasinghe D., Tangrea J.A., Andersen M.R., Barrett M.J., Virtamo J., Taylor P.R., et al. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res 2000, 60:6381-6383.
35. Nahon P., Sutton A., Rufat P., Charnaux N., Mansouri A., Moreau R., et al. A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis. J Hepatol 2012, 56(2):426-432.
36. Sfar S., Jawed A., Braham H., Amor S., Laporte, Kerkeni A. Zinc, copper and antioxidant enzyme activities in healthy elderly Tunisian subjects. Exp Gerontol 2009, 44(12):812-817.
37. Gärtner R., Angstwurm M. Significance of selenium in intensive care medicine. Clinical studies of patients with SIRS/sepsis syndrome. Med Klin 1999, 94(3):54-57.
38. Berger M.M. Antioxidant micronutrients in major trauma and burns: evidence and practice. Nutr Clin Pract 2006, 21:438-449.
39. Cox D.G., Tamimi R.M., Hunter D.J. Gene X Gene interaction between MnSOD and GPX-1 and breast câncer risk: a nested case-control study. BMC Cancer 2006, 6:217.
40. Ichimura Y., Habuchi T., Tsuchiya N., Wang L., Oyama C., Sato K., et al. Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant. J Urol 2004, 172(2):728-732.
41. Sutton A., Nahon P., Pessayre D., Rufat P., Poiré A., Ziol M., et al. Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol induced cirrhosis. Cancer Res 2006, 66:2844-2852.
42. Choi J.Y., Neuhouser M.L., Barnett M.J., Hong C.C., Kristal A.R., Thornquist M.D., et al. Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. Carcinogenesis 2008, 29:964-970.
43. Jablonska E., Gromadzinska J., Reszka E., Wasowicz W., Sobala W., Szeszenia-Dabrowska N., et al. Association between GPx1 Pro198Leu polymorphism, GPx1 activity and plasma selenium concentration in humans. Eur J Nutr 2009, 48:383.
44. Goldberg A.D., Allis C.D., Bernstein E. Epigenetics: A Landscape Takes Shape. Cell 2007, 128(4):635-638.
45. Tang W.Y., Ho S. Epigenetic Reprogramming and Imprinting in origins of disease. Rev Endocr Metab Disord 2007, 8(2):173-182.
46. Graves B.T., Munro C.L. Epigenetics in critical illness: a new frontier. Nurs es Pract 2013, 503686.